How many times a day should Elafibranor be taken and how much should it be taken?

Elafibranor is a drug that targets peroxisome proliferator-activated receptor α/δ (PPAR α/δ) oral drugs are mainly used to treat non-alcoholic steatohepatitis (NASH) and related metabolic diseases. Its mechanism of action is to regulate lipid metabolism, insulin sensitivity, and inhibit liver inflammation and fibrosis processes. As the incidence of NASH increases year by year, elafibratenol has gradually attracted attention as a non-invasive treatment option.

As for the dosage, the recommended dosage of elafibratenol in clinical trials is mainly 80mg once a day or 120mg once a day. The study found that the 80mg dose can produce good efficacy while ensuring safety; while the 120mg dose is more significant in improving liver tissue inflammation and fibrosis. However, the specific dosage needs to be adjusted individually based on the doctor's assessment of the patient's condition, weight, liver function indicators, and tolerance to the drug.

Patients usually take irafibratenol once in the morning on an empty stomach or before meals and at the same time every day to help maintain stable blood concentration. Long-term adherence to standardized medication is the key to achieving therapeutic effects. It is worth noting that elafibratenol is still undergoing late-stage clinical research for some indications and has not been officially approved for marketing in some countries. Therefore, patients should strictly follow the doctor's guidance before taking it and avoid increasing or decreasing the dose or frequency on their own.

Overall, the simple, once-daily dosing design of elafibratenol improves patient compliance. However, because it may have an impact on cholesterol levels, liver enzyme indicators, and cardiovascular metabolism, it is recommended that patients undergo regular checks on liver function, blood lipids, and blood sugar during the medication period to grasp the efficacy and body response of the medication in a timely manner to ensure the safety and effectiveness of the medication. For patients with impaired liver function or other metabolic diseases, doctors may adjust the dosage appropriately to ensure individualization and precision of treatment.

Reference materials:https://www.drugs.com/donanemab.html